Rapid investigation of BA.4/BA.5 cases in France

20228 citationsJournal Articlegold Open Access

Authors

Alain-Claude Kouamen · Santé Publique France

Helena Da Cruz · Santé Publique France

Mohamed Hamidouche · Institut thématique Santé Publique

Anaïs Lamy · Santé Publique France

Anna Lloyd · Santé Publique France

Javier J. Castro Alvarez · Santé Publique France

Mathilde Roussel

Abstract

Despite the longer duration of and the differences in symptoms and their possible immune escape, BA.4/BA.5 Omicron sub-lineages globally showed no severe clinical presentation. The presence of at least one risk factor for severe disease significantly increased the risk of hospitalization for those infected with BA.4 or BA.5.

Topics & Keywords

Bacillus and Francisella bacterial research Clostridium difficile and Clostridium perfringens research Viral gastroenteritis research and epidemiology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Frontiers in Public Health

Volume 10, pp. 1006631-1006631

DOI: 10.3389/fpubh.2022.1006631

Field-Weighted Citation Impact: 0.69